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ABSTRACT 
 Health disparities in African Americans is a persistent issue. Higher rates and severity of 
the novel coronavirus-19 [COVID-19] among African Americans only widens health disparities. 
Effective COVID-19 treatment options are imperative, requiring representation of African 
Americans in clinical research. However, low participation and under-representation of African 
Americans is complex in nature. This article describes health disparities, the impact of COVID-
19, and participation in clinical research among African Americans. We offer strategies for 
researchers to enhance the inclusion of African Americans. We also offer strategies in conducting 
clinical research during COVID-19. 
 
 Keywords: African Americans, health disparities, COVID-19, and research participation 
 
HEALTH DISPARITIES AMONG AFRICAN AMERICANS 
Non-Hispanic Black adults (ages 65 years or younger) have higher levels of chronic 
diseases such as hypertension, diabetes, and stroke when compared to non-Hispanic White adults 
(Centers for Disease Control and Prevention, 2017; (Cunningham et al., 2017) and higher mortality 
from cardiovascular disease and cancer (Cunningham et al., 2017). Cancer is the leading cause of 
death among African Americans (Jemal et al., 2017). Evidence also supports how African 
American, Hispanic or Latino, and American Indian or Alaska Native communities are 
disproportionately affected by the novel coronavirus, COVID-19 (Centers for Disease Control and 
Prevention [CDC], 2020d; Yancy, 2020). Approximately 90% of disproportionately Black 
counties reported a COVID-19 case and 49% reported a COVID-19 related-death versus 81% and 
28%, respectively, for all other counties (Millett et al., 2020). Cities such as Milwaukee, St. Louis, 
Chicago, New York City, which are characterized by large African American populations, are 
being hit hard by COVID-19 (Millett et al., 2020). Age-adjusted COVID-19 related hospitalization 
rates show that non-Hispanic Blacks have a rate at 178, which is approximately five times that of 
non-Hispanic Whites at 40 (CDC, 2020b).  
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Health disparities among African Americans arise from an interplay of racial, social, and 
gender disparities in which the main social determinants of health are racism, poverty, educational 
level, environmental and living conditions (e.g., housing and exposures within the environment), 
access to healthy foods, violence, and inequities in criminal justice (Noonan et al., 2016). The call 
to eliminate health disparities and achieve health equity in African Americans is not a new issue 
(Noonan et al., 2016).   
COVID-19 highlights the disparities experienced by African Americans. Social conditions, 
structural racism, and other factors contribute to the higher risks linked to COVID-19 in African 
American communities (Millett et al., 2020), and structural racism is the root cause of health 
disparities (Yearby, 2020). Table 1 provides an overview of some of these factors. Social 
distancing, one highly effective way to prevent the spread of COVID-19, is not easily actionable 
for some African Americans (Yancey, 2020).  
 
Table 1. Factors Contributing to Higher COVID-19 Risks  
Conditions Description 
Living  Residence in densely populated area 
increasing exposure to COVID-19. 
Living in low-income households, 
crowded conditions elevating 
exposure, and minimum options to 
quarantine (Adamkiewicz et al., 2011; 
Centers for Disease Control and 
Prevention [CDC], 2020b; U.S. 
Bureau Labor Statistics, 2018).  
Working Serving as an essential worker, lack of 
ability to take a sick leave or stay 
home from work (CDC, 2020b). 
Health Pre-existing health/medical conditions; 
Uninsured or underinsured, resulting 
in lack of access to healthcare service 
and absence of timely care (CDC, 
2020b; 2020c). 
 
Structural Racism  The structure of health care, education, 
employment, housing, and public  
health systems that create inequalities 
among racial and ethnic minority 
groups (Yearby, 2020).  
 
Participation in research is crucial to assess the safety and efficacy of new treatments for 
African Americans to reduce health disparities (Harris et al., 1996). The underrepresentation of 
African Americans in clinical research is complex, with multiple contributing factors (e.g., 
socioeconomic and environmental) that create barriers to participation are described in Table 2. 
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Due to a long history of racism and incidences of unethical conduct in the medical and scientific 
community, African Americans are reluctant to participate in research (Harris et al., 1996; Schaff 
et al., 2010; Otado et al., 2015). Mistrust of medical research and the health care system is 
extensive (Scharff et al., 2010) and heavily cited as a barrier to research participation (Harris et 
al., 1996; Schaff et al., 2010; Williams et al., 2010). Researchers should address all barriers to 
participation, and addressing mistrust is paramount.  
 
Table 2. Barriers to Research Participation among African Americans 
Past abuse in medical experimentation (e.g., Tuskegee Study) 
Fear and social stigma (i.e., stereotyping or labeling as a research participant) 
Negative personal experiences with the health care system, such as institutional racism and 
differential treatment 
Feelings of mistrust 
The nature of the experimentation involved in higher risk intervention research 
Educational level (i.e., education disadvantage)  
Communication issues (i.e., absence of addressing concerns during recruitment phase and 
duration of the study) 
Logistical issues (e.g., time commitment and expenses as a research participant creating a 
general inconvenience) 
Lack of awareness (i.e., ineffective recruitment efforts by researchers) 
Compensation 
Lack of interest and confidence in clinical research 
 Note. Adapted from literature (Centers for Disease Control and Prevention, 2020a; Ford et al., 
2013; George et al., 2014; Huang & Coker, 2010; Luebbert & Perez, 2016; Otado et al., 2015; 
Savitt, 2002; Scharff et al., 2010; Tanner et al., 2015; Washington, 2006).  
 
RESEARCH PARTICIPATION IN CLINICAL TRIALS AMONG AFRICAN 
AMERICANS 
Historically, African Americans have been underrepresented in clinical trials (Harris et al., 
1996; Tufts Center for the Study of Drug Development, 2020) even when the illness 
disproportionately affects the African American population, such as cardiovascular disease, 
cancer, and diabetes (Centers for Disease Control and Prevention, 2017; Cunningham et al., 2017; 
Khan et al., 2020). Approximately 4% were non-Hispanic Blacks when compared to non-Hispanic 
Whites at 81% among clinical trial research for cardiovascular and diabetes mellitus drugs (Khan 
et al., 2020). Moreover, the enrollment of African Americans in pivotal clinical trials, such as 
multiple myeloma clinical trials are 0.5% to 19.9% (Bhatnagar et al., 2017) while African 
American participation in human immunodeficiency virus (HIV) vaccine trials are 17.3% 
(Huamani et al., 2019). The participation of Africans Americans in global clinical trials for 
oncology treatments are 2.7% (U.S. Food & Drug Administration, 2017). 
The problem of underrepresentation in clinical trials is important because the efficacy and 
acceptability of treatment options may vary based on an individual’s racial or ethnic background 
(Buchard et al., 2003). Clinical trials aid in the development of effective treatment options such as 
drug efficacy and safety⎯but how will this be achieved when research conducted lacks adequate 
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representation of African Americans? Achieving health equity cannot occur unless research 
includes African American participants (Warren et al., 2019). Researchers must build trust to 
obtain adequate representation of African Americans in research to reduce health disparities 
(Akintobi et al., 2020; Luebbert & Perez, 2016). An integral component of trust-building is 
establishing effective partnerships with the community (Akintobi et al., 2020). Table 3 describes 
best practices for recruitment, retention, and inclusion of African Americans in clinical research. 
 
Table 3. Recruitment, Retention, and Inclusion Strategies for African Americans  
Strategy Description  
Develop a clear recruitment and retention plan Researcher dedicates time prior to the 
implementation of a clinical trial to: 
• develop and implement 
culturally tailored study 
materials (Luebbert & Perez, 
2016),  
• pay special attention to inclusion 
and exclusion criteria (Langford 
& Bateman, 2020),  
• minimize participant burden in 
both trial enrollment 
participation in the study 
(Langford & Bateman, 2020), 
and  
• ensure that adequate resources 
are allocated for recruitment and 
retention of diverse participants 
(Jimenz & Czaja, 2015). 
Utilize multiple recruitment strategies  Word of mouth, inform about the 
potential impact of study findings on 
health disparities, and circulate 
culturally-tailored materials such as 
flyers or advertising in newspapers 
within African American communities 
(Otado et al., 2015; Scharff et al., 2010).  
 
 
Increase knowledge of social issues within the 
African American community 
Conduct training for all research staff on 
the research process and on 
sociocultural factors of the African 
American population (Luebbert & 
Perez, 2016). 
Field based approach Dedicate time to go into the 
communities to have a presence, 
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develop community partnerships, build 
relationships, and establish rapport with 
community members (Otado et al., 
2015; Scharff et al., 2010). 
 Culturally competent research teams  A study team of African American  
investigators and coordinators who 
actively engage with target African 
American communities, demonstrating 
trust and respect to 
study participants and potential 
participants, to deliver culturally 
relevant information about the research 
project (Otado et al., 2015) and potential 
impact of the study findings on health 
disparities (Scharff et al., 2010).  
Establish effective partnerships Involve the community in all phases of 
the research process: design, 
implementation, and evaluation to 
elevate communities as senior partners 
(Akintobi et al., 2020).  
 
Seek information from participants 
about the criteria that they use to 
evaluate trust in capacities of 
investigators and health care providers 
and institutions (Crawley, 2000). 
 
Obtain multi-leveled commitment to 
ensure tailored and culturally sensitive 
approaches (Sabatello et al., 2021).  
 
Work collaboratively with health care 
systems and providers to provide access 
to studies where participants reside and 
currently receive care and to increase 
awareness about clinical trials. 
(Langford & Bateman, 2020). 
 
Address health literacy levels of study 
participants 
Assess readability levels of study 
materials; develop study materials that 
are understandable to participants that 
possibly low literacy readers (Taani, 
2020).  
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Post-visit follow-ups Make phone calls to participants to 
inquire about their general well-being 
(Otado et al., 2015).  
Provide frequent reminders Contact participants with reminders 
prior to upcoming appointments (Otado 
et al., 2015). 
Offer additional incentives for each follow-up 
visit  
Offer parking validation tickets, snacks, 
or lunch coupons (Otado et al., 2015). 
Flexible scheduling  Acknowledgement and respect of 
participants’ time and schedules by 
including after work hours and weekend 
study visits (Otado et al., 2015). 
Displaying respect  Encouraging participants to voice their 
concerns related to the study and in 
general and listening to those concerns; 
being sensitive to their needs (Otado et 
al., 2015). 
Convenience of participation Addressing the logistic barriers to 
participation [i.e., covering 
transportation costs, visits/meetings 
conducted at a site nearby public 
transportation, childcare availability at 
the visit for parents, and providing travel 
vouchers] (Otado et al., 2015). 
 
In light of the underrepresentation of African Americans in clinical trials, determining the 
efficacy of COVID-19 vaccines or treatments are bleak. African Americans possess mixed feelings 
toward vaccines due to previous measles, mumps, and rubella (MMR) vaccines (Pew Research 
Center, 2017) and are less likely to receive other types of vaccines such as influenza vaccine and 
pneumococcal vaccine (U.S. Department of Health and Human Services, 2018). However, African 
Americans (41%) reported benefits in allowing access to experimental COVID-19 treatments 
before clinical trial completion (Pew Research Center, 2020). Most African Americans (54%) also 
reported they would get a COVID-19 vaccine if available today (Pew Research Center, 2020). The 
identification of effective and trustworthy COVID-19 vaccines and treatments requires adequate 
representation of African Americans in clinical trials. Once efficacy and safety is determined of 
treatment options for African Americans, those options should be affordable and readily accessible 
(Wen & Sadeghi, 2020).  
 
CONDUCTING RESEARCH DURING COVID-19  
Clinical research has been affected by COVID-19 in which studies have been halted as a 
result of redirection of resources and in-person-visits (Tuttle, 2020). The disruption in clinical 
trials conducted and its impact on patient care is potentially devastating. For example, clinical 
trials for oncology patients are needed during this time and should resume (Cooney, 2020). Due to 
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adherence to social and physical distancing, face-to-face interactions in the homes, churches, and 
other community settings have been prevented which present challenges to community 
engagement. Social distancing limitations have influenced the ability to establish human 
connection and in-person exchanges (Akintobi et al., 2020). We offer strategies to consider in 
conducting research during COVID-19 (see Table 4) that should be applied in addition to the 
strategies used to recruit and retain African American participants. 
 
Table 4. Recommendations for Conducting Research during COVID-19 
Strategy Description 
Modify research and data analysis As research involving face-to-face 
interactions is minimized, prepare for remote 
data collection and ensure proper connections 
for videoconferencing (Clay, 2020). 
 
Consult with your institution  Researchers will need to follow guidelines 
and directives by their institution in resuming 
research, screening research participants 
(Clay, 2020). 
Protect research participants Benefits to patients must outweigh the risk 
(Clay, 2020). 
Inform about required changes in protocol 
and the potential risk(s) associated with study 
participation (McDermott & Newman, 2020).  
Maintain communication with research team 
and staff 
Frequent communication is important to keep 
the research project going and safeguarding 
the mental health of your team members. 
(Clay, 2020). 
Maintain communication with study 
participants 
Use telephone, email, and the electronic 
health record portal to provide study updates 
(Tuttle, 2020). 
Adhere to social distancing policies Incorporate the telephone, video tools, or 
wearables for data collection (Langford & 
Bateman-House, 2020).  
 
Require masks and physical distancing and 
restrict visitors to the absolute minimum 
number needed (Tuttle, 2020).  
Implement new modes of community 
engagement  
With face-to-face interactions limited, utilize 
webinars and digital technology formats 
(Akintobi et al., 2020). 
 
To conclude, COVID-19 sheds light on the interplay of racial and social disparities coupled 
with social determinants of health that contribute to health disparities in African Americans. 
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COVID-19 has exacerbated disparities but also presents an opportunity to work to achieve health 
equity in African Americans (van Dorn et al., 2020; Hooper et al., 2020). Researchers are 
encouraged to pay close attention to building trust when conducting research among African 
Americans. Our hope is that this discussion adds perspective regarding the need to identify 
effective recruitment and retention strategies that aid in the inclusion of African Americans in 




Adamkiewicz, G. Zota, A.R., Fabian, P.M., Chahine, T., Julien, R., Spengler, J.D., & Levy, J.I. 
(2011). Moving environmental justice indoors: understanding structural influences on 
residential exposure patterns in low-income communities. American Journal of Public 
Health, 101(S1), S238-S245. https://doi.org/10.2105/AJPH.2011.300119 
Akintobi, T.H., Jacobs, T., Sabbs, D., Holden, K., Braithwaite, R., Johnson, N., Dawes, D., & 
Hoffman, L. (2020). Community engagement of African American s in the era of COVID-
19 considerations, challenges, implications, and recommendations for public health. 
Preventing Chronic Disease, 17: 200255. http://dx.doi.org/10.5888/pcd17.200255 
Bhatnagar, V., Gormley, N., Kazandjian, D., Goldberg, K., McKee, A.E., Blumenthal, G., Farrell, 
A.T., & Pazdur, R. (2017). FDA analysis of racial demographics in multiple myeloma 
trials.  Blood, 130(Supplement 1), 4352. 
https://doi.org/10.1182/blood.V130.Suppl_1.4352.4352 
Burchard, E.G, Ziv, E., Coyle, N., Gomez, S.L., Tang, H., Karter, A.J, Mountain, J.L., Pérez-
Stable, E.J., Sheppard, D., & Risch, N. (2003). The importance of race and ethnic 
background in biomedical research and clinical practice. NEJM, 348(12), 1170–1175. doi: 
10.1056/nejmsb025007. 
Center for Disease Control and Prevention. (2017, May 2). Vital signs; African American health. 
Retrieved from https://www.cdc.gov/vitalsigns/aahealth/infographic.html 
Center for Disease Control and Prevention [CDC]. (2020a, March 2). U.S. Public Health Service 
syphilis study at Tuskegee: the Tuskegee timeline. CDC. Retrieved from 
https://www.cdc.gov/tuskegee/timeline.htm 
Center for Disease Control and Prevention.  (2020b, June 25). COVID-19 in racial and ethnic 
minority groups. Retrieved from https://www.cdc.gov/coronavirus/2019-ncov/need-extra-
precautions/racial-ethnic-minorities.html 
Center for Disease Control and Prevention. (2020c, July 20). People with certain medical 




Centers for Disease Control and Prevention. (2020d, August, 18). COVID-19 hospitalization and 
death by race/ethnicity. https://www.cdc.gov/coronavirus/2019-ncov/covid-
data/investigations-discovery/hospitalization-death-by-race-ethnicity.html 
 
61 Health Disparities and COVID-19 Pandemic: Increasing Clinical Research Participation 
among African Americans 
Webber-Ritchey and Lane-Cordova 
 
Journal of Health Disparities Research and Practice Volume 14, Issue 2, Summer 2021 
 http://digitalscholarship.unlv.edu/jhdrp/    
Follow on Facebook:  Health.Disparities.Journal 
Follow on Twitter:  @jhdrp 
Clay, R.A (2020). Conducting research during COVID-19 Pandemic Advice form psychological 
researchers on protecting participants, animals, and subject. Retrieved from 
https://www.apa.org/news/apa/2020/03/conducting-research-covid-19 
Cooney, E. (2020). Ignoring cancer care now may trade one public health crisis—Covid-19—for 
another, NCI chief warns. STAT. Retrieved from 
https://www.statnews.com/2020/06/19/ignoring-cancer-care-covid-19-nci-sharpless/ 
Crawley, L.M. (2000). African-American participation in clinical trials: situating trust and 
trustworthiness. Journal of the National Medical Association, 93, 12, 14S-17S.  
Cunningham, T.J., Croft, J.B., Liu, Y., Lu, H., Eke, P.I,. Giles, W.H. (2017). Vital signs: Racial 
disparities in age-specific mortality among Blacks or African Americans — United States, 
1999–2015. MMWR and Morbidity and Mortality Weekly Report, 66:444–456. doi: 
http://dx.doi.org/10.15585/mmwr.mm6617e1External. 
George, S., Duran, N., & Norris, K. (2014). A systematic review of barriers and facilitators to 
minority research participation among African Americans, Latinos, Asian Americans, and 
Pacific Islanders. American Journal of Public Health, 104(2), e16-e31. 
doi:10.2105/AJPH.2013. 
Ford, M.E., Siminoff, L.A., Pickelsimer, E., Mainous, A.G., Smith, D.W., Diaz, V.A.…Tilley, 
B.C. (2013). Unequal burden of disease, unequal participation in clinical trials: Solutions 
from African American and Latino community members. Health & Social Work, 38(1), 
29-38. doi: 10.1093/hsw/hlt001 
Harris, Y., Gorelick, P.B., Samuels, P., & Bernpong, I. (1996). Why African Americans may not 
be participating in clinical trials. Journal of the National Medical Association, 88(10).  
Hooper, M.W., Nápoles, A.M., & Pérez-Stable, E.J. (2020). Covid-19 and racial/ethnic disparities. 
JAMA, 323(24), 2466-2467. doi:10.1001/jama.2020.8598 
Huang, H.H. & Coker, A.D. (2010). Examining issues affecting African American participation in 
research studies. Journal of Black Studies, 40(4), 619-636. doi: 
10.1177/0021934708317749  
Huamani, K.F., Metch, B., Broder, G., & Andrasik, M. (2019). A demographic analysis of 
racial/ethnic minority enrollment into HVTN preventive early phase HIV vaccine clinical 
trials conducted in the United States, 2002-2016. Public Health Reports, 134(1), 72-80. 
Retrieved from https://doi.org/10.1177%2F0033354918814260 
Jemal, A., Ward, E.M., Johnson, C.J., Cronin, K.A., Ma, J., Ryerson, A.B.,…Weir, H.K. (2017).  
Annual report to the nation on the status of cancer, 1975–2014, featuring survival. JNCI: 
Journal of the National Cancer Institute, 109 (9). https://doi.org/10.1093/jnci/djx030 
Jimenez, D.E. & Czaja, S.J. (2015). Recruitment and retention: two of the most important, yet 
challenging, tasks in behavioral intervention research. In L. Gitlin & S. Czaja, S. (Eds.)., 
Behavioral intervention research: designing, evaluating, and implementing (pp. 177-194). 
Springer Publishing Company.  
Khan, M.S., Shahid, I., Siddiqi, T.J., Khan, S.U., Warraich, H.J., Greene, S.J., Butler, J., & Michos, 
E.D. (2020). Ten-year trends in enrollment of women and minorities in pivotal trials 
supporting recent US food and drug administration approval of novel cardiometabolic 
drugs. Journal of the American Heart Association, 9, e015594. 
https://doi.org/10.1161/JAHA.119.015594 
62 Health Disparities and COVID-19 Pandemic: Increasing Clinical Research Participation 
among African Americans 
Webber-Ritchey and Lane-Cordova 
 
Journal of Health Disparities Research and Practice Volume 14, Issue 2, Summer 2021 
 http://digitalscholarship.unlv.edu/jhdrp/    
Follow on Facebook:  Health.Disparities.Journal 
Follow on Twitter:  @jhdrp 
Langford, A.T. & Bateman-House, A. (2020, June 12). Clinical trials for COVID-19: populations 
most vulnerable to COVID-19 must be included. Health Affairs Blog. doi: 
10.1377/hblog20200609.555007 
Luebbert, R. & Perez, A. (2016). Barriers to clinical research participation among African 
Americans. Journal of Transcultural Nursing,27(5), 456-463. doi: 
10.1177/1043659615575578. 
McDermott, M.M. & Newman, A.B. (2020). Preserving clinical trial integrity during the 
Coronavirus pandemic. JAMA, 323(21):2135–2136. doi:10.1001/jama.2020.4689 
Millett, G.A., Jones, A.T., Benkenser, D., et al. (2020). Assessing differential impacts of COVID-
19 on black communities. Annals of Epidemiology, 47, 37-44. 
https://doi.org/10.1016/j.annepidem.2020.05.003 
Noonan, A. S., Velasco-Mondragon, H.E., & Wagner, F.A. (2016). Improving the health of 
African Americans in the USA: Overdue opportunity for social justice. Public Health 
Reviews, 37(12). doi: 10.1186/s40985-016-0025-4 
Otado, J., Kwagyan, J., Edwards, D., Ukaegbu, A., Rockcliffe, F., & Osafo, N. (2015). Culturally 
competent strategies for recruitment and retention of AA populations into clinical trials. 
Clinical and Translational Science, 1-7, doi: 10.1111/cts.12285 
Pew Research Center. (2017, February). Vast majority of Americans say benefits of childhood 
vaccines outweigh risks. Retrieved from https://www.pewresearch.org/internet/wp-
content/uploads/sites/9/2017/02/PS_2017.02.02_Vaccines_FINAL.pdf 
Pew Research Center. (2020 May). Trust in medical scientists has grown in U.S., but mainly 
among Democrats. https://www.pewresearch.org/science/2020/05/21/trust-in-medical-
scientists-has-grown-in-u-s-but-mainly-among-democrats/ 
Sabatello, M., Jackson Scroggins, M., Goto, G., Santiago, A., McCormick, A., Morris, K., 
Daulton, C., Easter, C., & Darien, G. (2021). Structural racism in the COVID-19 pandemic: 
moving forward. American Journal of Bioethics, 21(3), 56–74. 
https://doi.org/10.1080/15265161.2020.1851808 
Savitt, T.L. (2002). Medicine and slavery: the diseases and health care of Blacks in Antebellum 
Virginia. University of Illinois Press.  
Scharff, D.P., Matthews, K.J., Jackson, P., Hoffsuemmer, J., Martin, E., & Edwards, D. (2010). 
More than Tuskegee: understanding mistrust about research participation. Journal of 
Health Care for the Poor and Underserved,21 (3), 879-897. doi:10.1353/hpu.0.0323. 
Taani, M. H., Zabler, B., Fendrich, M., & Schiffman, R. (2020). Lessons learned for recruitment 
and retention of low-income African Americans. Contemporary Clinical Trials 
Communications, 17, 100533. https://doi.org/10.1016/j.conctc.2020.10053  
Tanner, A., Kim, S.H., Friedman, D.B., Foster, C., & Bergeron, C.D. (2015). Barriers to medical 
research participation as perceived by clinical trial investigators: Communicating with 
rural and African American communities. Journal of Health Communication, 20, 88-96. 
doi:10.1080/10810730.2014.908985  
Tufts Center for the Study of Drug Development. (2020). New benchmarks quantify demographic 
under-representation in clinical trials. Impact Report, 22(3). Retrieved from 
https://static1.squarespace.com/static/5a9eb0c8e2ccd1158288d8dc/t/5eba9c7f88fde7250a
e09018/1589288064256/mayjuneir2020_csddsummary.png.  
63 Health Disparities and COVID-19 Pandemic: Increasing Clinical Research Participation 
among African Americans 
Webber-Ritchey and Lane-Cordova 
 
Journal of Health Disparities Research and Practice Volume 14, Issue 2, Summer 2021 
 http://digitalscholarship.unlv.edu/jhdrp/    
Follow on Facebook:  Health.Disparities.Journal 
Follow on Twitter:  @jhdrp 
Tuttle, K.R. (2020). Impact of the COVID-19 pandemic on clinical research. Nature, 16, 562=-
564.  
U.S. Bureau of Labor Statistics. (2018, July). A profile of the working poor, 2016. BLS Reports. 
Retrieved from https://www.bls.gov/opub/reports/working-poor/2016/home.htm 
U.S. Department of Health Services. (2018). Immunizations and African Americans. Retrieved 
from https://minorityhealth.hhs.gov/omh/browse.aspx?lvl=4&lvlid=22 
U.S. Food & Drug Administration. (2017, July). Global participation in clinical trials report 2015-
2016. Retrieved from https://www.fda.gov/media/106725/download 
van Dorn, A., Cooney, R.E., & Sabin, M.L. (2020). COVID-19 exacerbating inequalities in the 
US. Lancet, 395(10232), P1243-P1244. Retrieved from https://doi.org/10.1016/S0140-
6736(20)30893-X 
Warren, R.C., Shedlin, M.G., Alema-Mensah, E., Obasaaju, C., Hodge, D.A. (2019). Clinical trials 
participation among African Americas and the ethics of trust: Leadership perspectives. 
Ethics, Medicine, and Public Health, 10, 128-138. Retrieved from 
https://doi.org/10.1016/j.jemep.2019.100405 
Washington, H. (2006). Medical apartheid: The dark history of medical experimentation on black 
Americans from colonial times to the present (1st ed.).  Doubleday.  
Wen, L.S. & Sadeghi, N.B. (2020). Addressing racial health disparities in the COVID-19 
pandemic: immediate and long-term policy solutions. doi:10.1377/hblog20200716.620294 
Williams, M.M., Scharff, D.P., Matthews, K.J., Huffsuemmer, J.S., Jackson, P., Morris, J.C., & 
Edwards, D.F. (2010). Barriers and facilitators of African American participation in 
Alzheimer disease biomarker research. Alzheimer Disease and Associated Disorders, 
24(suppl): S24-S29. doi:10.1097/WAD.0b013e3181f14a14. 
Yancy, C.W. (2020). COVID-19 and African Americans. JAMA, 323(19). 
doi:10.1001/jama.2020.6548 
Yearby, R. (2020). Structural racism and health disparities: Reconfiguring the social determinants 
of health framework to include the root cause. The Journal of Law, Medicine & Ethics, 
48(3), 518–526. Retrieved from https://doi.org/10.1177/1073110520958876 
 
 
 
